Mycronic AB (publ) (STO:MYCR)
Sweden · Delayed Price · Currency is SEK | Market Cap | 54.45B +29.1% |
| Revenue (ttm) | 9.30B +16.6% |
| Net Income | 1.99B +14.2% |
| EPS | 10.19 +14.2% |
| Shares Out | 195.29M |
| PE Ratio | 27.36 |
| Forward PE | 30.03 |
| Dividend | 3.25 (1.17%) |
| Ex-Dividend Date | May 7, 2026 |
| Volume | 307,646 |
| Open | 276.00 |
| Previous Close | 275.40 |
| Day's Range | 270.60 - 280.80 |
| 52-Week Range | 183.32 - 364.40 |
| Beta | 0.66 |
| Analysts | Hold |
| Price Target | 319.00 (+14.42%) |
| Earnings Date | Oct 22, 2026 |
About Mycronic AB
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors. The PCB Assembly segment develops, manufactures, and markets flex... [Read more]
Financial Performance
In 2025, Mycronic AB's revenue was 7.94 billion, an increase of 12.48% compared to the previous year's 7.06 billion. Earnings were 1.56 billion, a decrease of -7.31%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for MYCR stock is "Hold." The 12-month stock price target is kr 319.00, which is an increase of 14.42% from the latest price.
News
Mycronic AB Earnings Call Transcript: Q3 2026
Q3 sales rose 38% to nearly SEK 2.4bn, with SEK 610m EBIT and record backlog above SEK 5.5bn. FY sales outlook was raised to SEK 9.75bn, while exceptional Global Technologies margins are not expected to repeat.
Mycronic AB Quarterly report: Q3 2026
Mycronic AB has published its Q3 2026 quarterly earnings report on October 22, 2026.
Mycronic AB Slides: Q3 2026
Mycronic AB has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 22, 2026.
Mycronic AB Transcript: CMD 2026
The event outlined a strategy to double sales to SEK 20 billion by 2032–2035, maintaining a 25% EBIT margin, driven by leadership in electronics production niches, new product launches, and active M&A. All divisions are expected to contribute to growth, with sustainability and innovation as core principles.
Mycronic AB Press release: FY 2026
Mycronic AB issued a press release on August 31, 2026, disclosing material business information to investors.
Mycronic AB Slides: FY 2026
Mycronic AB has posted slides in relation to its FY 2026 quarterly earnings report, which was published on August 31, 2026.
Mycronic AB Earnings Call Transcript: Q2 2026
Record order intake and strong sales growth were driven by robust demand across all divisions, especially Global Technologies. EBIT margin remained high at 29%, and the full-year outlook was raised to SEK 9.25 billion, supported by capacity expansions and ongoing restructuring.
Mycronic AB Quarterly report: Q2 2026
Mycronic AB has published its Q2 2026 quarterly earnings report on July 14, 2026.
Mycronic AB Slides: Q2 2026
Mycronic AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 14, 2026.
Mycronic AB Earnings Call Transcript: Q1 2026
Q1 delivered record sales and EBIT, driven by strong demand in High Volume and Global Technologies, leading to an upgraded 2026 sales outlook. Pattern Generators saw robust sales but lower order intake, while PCB Assembly Solutions remained weak. AI and OLED trends continue to support growth.
Mycronic AB Quarterly report: Q1 2026
Mycronic AB has published its Q1 2026 quarterly earnings report on April 24, 2026.
Mycronic AB Slides: Q1 2026
Mycronic AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 24, 2026.
Mycronic AB Earnings Call Transcript: Q4 2025
Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with a stable backlog and continued R&D investment, while the outlook targets SEK 8.25 billion in sales for the year.
Mycronic AB Annual report: Q4 2025
Mycronic AB has published its Q4 2025 annual report on February 5, 2026.
Mycronic AB Quarterly report: Q4 2025
Mycronic AB has published its Q4 2025 quarterly earnings report on February 5, 2026.
Mycronic AB Slides: Q4 2025
Mycronic AB has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 5, 2026.